Nanobiotechnology
- biochemicalbreakdo
- May 20
- 6 min read
By Syona Podila
Imagine a world where tiny living things are modified by scientists to become new things and fix existing ones. This isn't science fiction anymore, it's Nanobiotechnology. Nanobiotechnology is a rapidly evolving field of science that has recently been taken in interest from the uprising of new technology and scientific developments. This new field of science is the application of nanotechnology which uses nano-tools and materials to study and apply to biological systems. Simply put, scientists are working inside a miniature world inside our cells where they can build on or create things using ultra-small tools and materials. Currently in the 21st century this field of science is being popularized due to the technological advancements it provides to manipulate materials at the atomic and molecular level, revolutionizing the scientific field. At this level, researchers often rely on bioconjugation techniques and molecular self-assembly to use nanoscale materials with living biological structures which allows precise interaction with cellular membranes.
Forget big data, we're talking TINY data! The implementation of nanotechnology in the biology field opens up the perspective of controlling matter at a nanoscale which allows the creation of new materials and enhancement to existing matter to create optimal results. This developing field of science is impacting areas in cell editing, diagnostics, and medicine with the goal to revolutionize these fields. Many of these innovations are driven by the use of quantum dots and functionalized nanoparticles that exhibit unique optical and electronic properties which brings advanced nanoscale manipulation.
Nanobiotechnology is taking gene editing from a blunt instrument to a laser scalpel. The magic word here is precision. Nanobiotechnology has been shown to improve cell editing and gene modification with precise reworking of cells to improve their stability, potential, and delivery. Think of nanotech as tiny helpers that can either mimic a cell's natural job or dive in to edit a damaged one. They can fortify a weakened cell by adding exactly the right missing nanoparticles, essentially giving it a superhero shield. In particular, the advantage of using nanotechnology is the precision that comes from the technology's ability to edit at a nanomicroscopic level which gives scientists more accuracy to stabilize a damaged cell. Not only does nanotechnology stabilize cells but it also strengthens one by adding lacking nanoparticles into the existing cell to really enforce a strong barrier to protect and make the cell a fort.
Now, for the reality check! When you start messing with the blueprint of life there are gonna be risks that appear. These tiny tools are so small they risk getting into places they shouldn't, which raises questions about whether we're ready for this level of human exposure to nanoparticles. Still, the potential is too huge to ignore. Studies show gene editing success rates are constantly climbing, proving that our microscopic building crew is getting better every day. As for the success of gene editing, the National Institute of Health showed that the success rate of gene editing can vary from 3% to 70.4% depending on the application of nanotechnology. Researchers also evaluate nanoparticle-driven genotoxicity using advanced assays to ensure that engineered particles do not disrupt DNA repair pathways or accumulate excessively in metabolic organs.
Another noteworthy biology field that nanotechnology is changing is the diagnostic sector across multiple medical fields. This technology gives way to early detection with the use of biomarkers that are increased in sensitivity and accuracy. Meet the medical field's best new spy team, Nanobio Diagnostics. This technology acts like microscopic detectives, finding diseases earlier and faster than ever before. How do they do it? They look for biomarkers which are the telltale chemical clues a disease leaves behind with incredible sensitivity to detect. Yesterday's bulky diagnostic tools are gone. Today, nanotech can diagnose on the spot!
According to the Scirp Journal Nanotechnology has risen from 25 billion in 2000 to 225 in 2020 and projected to continue growing rapidly. Not only is nanotechnology impacting the medical field for diagnosis but it is also a part of detecting plant diseases. Specifically, nanotechnology is acting similar to detecting diseases in humans as it is for plants, using the technology farmers are able to sense if their crops are attaining new diseases and how likely their plants are to withstand them. Although this feels like science fiction, it's real, and it's making massive progress in the agriculture sector with early detection and prevention from farmers’crops failing. With early detection in both the medical field and agriculture sector, nanotechnology has shown the trend of reducing the percentage of fatality and risk from disease.
Lastly nanotechnology is majorly impacting the category of medicine through multiple ways including drug delivery, imaging, and surgery performance. Because nanobiotechnology makes it possible to have highly specific and efficient drug delivery systems with minimal cell damage to healthy cells, it is revolutionizing the medical field. Therapies are being designed to have straight action on infected or cancerous tissue with no activity against tissue using nanoparticles. This improves therapy efficiency and decreases negative side effects.
The actual breakthrough is the nanoscopic size of particles that allows them to cross biological barriers like the blood-brain barrier, a highly protected defense system that has long been the ultimate obstacle for traditional therapies. A 2023 Nature Nanotechnology article claims that researchers have been able to deliver mRNA into brain tumors using lipid-based nanoparticles, a new possibility in treating advanced brain tumors like glioblastoma.
While such breakthroughs are encouraging, toxicity concerns are still at large. Because nanoparticles are so small, they have the potential to build up in organs like the liver or spleen and cause inflammation or damage to tissue over time. Ethical implications from unexpected side effects are also shown by the limited availability of long-term studies on nanomaterials in the human body. Toxicologists often measure nanoparticle-induced oxidative stress and inflammatory cytokine expression, which are two key biomarkers that indicate whether nanomaterials may compromise long-term cellular health.
While regulations for the safe use of nanomedicine products remain a work in progress, the FDA reports that this business is booming. Despite these critical reservations, nanobiotechnology is undeniably one of the most revolutionary devices in medicine capable of identifying and treating diseases with accuracy never before seen at the cellular level.
In short, nanobiotechnology is of scientific achievement, and it offers multiple solutions for cell editing, diagnostics, and medicine. Its ability to engineer matter at the molecular level is changing the way in which we detect, treat, and prevent diseases in humans and also in agriculture. Although its potential is great, constant research and ethical issues remain to ensure it is safe and dependable to use. As the world continues to evolve, nanobiotechnology has the potential to reshape modern science.
Key Words:
Bioconjugation techniques – methods of chemically linking biomolecules to nanoparticles.
Molecular self-assembly – process where molecules autonomously organize into complex structures.
Quantum dots – nanoscale semiconductor particles with unique fluorescent properties.
Functionalized nanoparticles – nanoparticles modified with chemical groups to interact with specific cells or proteins.
Genotoxicity- the ability of a substance to damage DNA.
Oxidative stress- cell damage caused by reactive oxygen species.
Inflammatory cytokine expression- immune signals produced when tissue becomes inflamed.
Works Cited
“Nanobiotechnology.” Google Books, 2019,
books.google.com/books?hl=en&lr=&id=FPCbDwAAQBAJ&oi=fnd&pg=PA1&dq=nanobiotechnology&ots=q5GSNso41v&sig=KnJipoy1ZLHrTLQUy-2yhAHjLC4#v=onepage&q=nanobiotechnology&f=false. Accessed 28 July 2025.
Md Fakruddin, et al. “Prospects and Applications of Nanobiotechnology:
A Medical Perspective.” Journal of Nanobiotechnology, vol. 10, no. 1, 1 Jan. 2012, pp. 31–31, link.springer.com/article/10.1186/1477-3155-10-31, https://doi.org/10.1186/1477-3155-10-31. Accessed 28 July 2025.
Alok Raghav, and Goo-Bo Jeong. “A Systematic Review on the Modifications of Extracellular Vesicles: A Revolutionized Tool of Nano-Biotechnology.” Journal of Nanobiotechnology, vol. 19, no. 1, 30 Dec. 2021, link.springer.com/article/10.1186/s12951-021-01219-2, https://doi.org/10.1186/s12951-021-01219-2. Accessed 28 July 2025.
P. Thamarai, et al. “Current Advancements in Nanotechnology for Stem Cells.” International Journal of Surgery, 5 Sept. 2024, pmc.ncbi.nlm.nih.gov/articles/PMC11634102/, https://doi.org/10.1097/js9.0000000000002082. Accessed 28 July 2025.
Shukla, Ritesh K, et al. “Genotoxic Potential of Nanoparticles: Structural and Functional Modifications in DNA.” Frontiers in Genetics, vol. 12, 29 Sept. 2021, pmc.ncbi.nlm.nih.gov/articles/PMC8511513/, https://doi.org/10.3389/fgene.2021.728250. Accessed 30 July 2025.
Lu, Xinyue, et al. “Applications and Research Advances in the Delivery of CRISPR/Cas9 Systems for the Treatment of Inherited Diseases.” International Journal of Molecular Sciences, vol. 24, no. 17, 25 Aug. 2023, pp. 13202–13202, pmc.ncbi.nlm.nih.gov/articles/PMC10487642/, https://doi.org/10.3390/ijms241713202. Accessed 30 July 2025.
“Nanobiotechnology Applications in Plant Protection.” SpringerLink, 2018, link.springer.com/book/10.1007/978-3-319-91161-8, https://doi.org/10.1007-978-3-319-91161-8. Accessed 30 July 2025.
Hamouda, Noura, et al. "Lipid Nanoparticles Delivering IL-21, IL-7, and 4-1BB Ligand mRNA for T Cell–Mediated Antitumor Immunity." Nature Communications, vol. 15, 2024, article no. 2391, https://www.nature.com/articles/s41467-024-54877-9.
Center. “Considerations for Drug Products That Contain Nanomaterials.” U.S. Food and Drug Administration, 2024, www.fda.gov/drugs/cder-small-business-industry-assistance-sbia/considerations-drug-products-contain-nanomaterials. Accessed 30 July 2025.
Comments